Healthcare Triangle, Inc. (HCTI) has completed a one-for-twenty (1:20) reverse stock split of its common stock, effective as of 12:01 a.m. Eastern Time on October 26, 2026. The split was implemented to address a potential delisting from the Nasdaq Capital Market. On October 1, 2026, the company received a Staff Delisting Determination from Nasdaq due to failure to meet the exchange's $1.00 minimum bid price requirement. Healthcare Triangle requested a hearing before a Nasdaq Hearings Panel on October 8, 2026, which is scheduled for November 5, 2026. The reverse split is intended to help the company regain compliance with Nasdaq's listing standards.
The reverse stock split reduced the number of issued and outstanding shares from 17,730,008 to 886,587 shares. The par value per share remains $0.00001, and the total number of authorized shares did not change. The transaction was effected through a Certificate of Amendment to the Amended Certificate of Incorporation filed with the Delaware Secretary of State. No fractional shares were issued; instead, stockholders entitled to fractional interests received additional fractions to round up to the next whole share. Proportional adjustments were made to outstanding warrants, stock options, and convertible securities.
Stockholders holding shares in brokerage accounts or "street name" do not need to take action. The Common Stock began trading on a split-adjusted basis on the Nasdaq Capital Market at the market open on October 26, 2026, under the existing trading symbol "HCTI." A new CUSIP number, 42227W 504, has been assigned. The Company’s transfer agent, VStock Transfer, LLC, acted as the exchange agent.
